Dofetilide: tritium labelling by several methods

Despite decades of research, heart disease remains a burden on global health, especially in developed countries. Among problematic cardiovascular indications, abnormal heart rhythms or arrhythmias play a significant role. Dofetilide is a unique cardiovascular drug and one of the earliest antiarrhyth...

Full description

Saved in:
Bibliographic Details
Published in:Journal of radioanalytical and nuclear chemistry 2024-04, Vol.333 (4), p.2081-2087
Main Authors: Egan, Judith A., Filer, Crist N., Pounds, Scot
Format: Article
Language:English
Subjects:
Chemistry
Chemistry and Materials Science
Diagnostic Radiology
Hadrons
Heart diseases
Heavy Ions
Inorganic Chemistry
Labeling
Mass spectrometry
Nuclear Chemistry
Nuclear Physics
Physical Chemistry
Public health
Tritium
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite decades of research, heart disease remains a burden on global health, especially in developed countries. Among problematic cardiovascular indications, abnormal heart rhythms or arrhythmias play a significant role. Dofetilide is a unique cardiovascular drug and one of the earliest antiarrhythmic agents. For many years, compounds labelled with tritium have been extremely useful to facilitate drug discovery research at the receptor level. This paper describes the tritium labelling of dofetilide by several methods. The syntheses and characterization of [phenyl- 3 H] dofetilide as well as [ N -methyl- 3 H] dofetilide are described in detail. ESI mass spectrometry was found to be an especially useful analytical tool to characterize these valuable radioligands. Because of synthetic efficiency and high specific activity, [ N -methyl- 3 H] dofetilide emerged as the preferred radioligand used by biologists worldwide and information about its storage and stability are also discussed.
ISSN:0236-5731
1588-2780
DOI:10.1007/s10967-024-09415-8